TruSight™ Oncology 500: a comprehensive tumor profiling assay
TruSight™ Oncology 500 is a comprehensive tumor profiling assay designed to identify known and emerging tumor biomarkers —including small variants, splice variants, and fusions. Importantly, TruSight Oncology 500 can measure tumor mutational burden (TMB) and microsatellite instability (MSI), features that are potentially key biomarkers for emerging immunotherapies.
Interested in finding out more? Click here
For Research Use Only. Not for use in diagnostic procedures.
QB# 7038